$IBRX INSIGHTS →IBRX up +9% premarket following continued strong news flow and expanding global commercialization of ANKTIVA.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →$IBRX INSIGHTS →$IBRX INSIGHTS →